Erythropoietin synthesis in renal myofibroblasts is restored by activation of hypoxia signaling

Journal of the American Society of Nephrology

Volumn 27, Issue 2, 2016, Pages 428-438

  Souma, Tomokazu ^a,b,c   Nezu, Masahiro ^a,b,c   Nakano, Daisuke ^b   Yamazaki, Shun ^a,b   Hirano, Ikuo ^a,b   Sekine, Hiroki ^a,b   Dan, Takashi ^b   Takeda, Kotaro ^d   Fong, Guo Hua ^d   Nishiyama, Akira ^e   Ito, Sadayoshi ^c   Miyata, Toshio ^b   Yamamoto, Masayuki ^a   Suzuki, Norio ^b  

^a Department of Medical Biochemistry ^*  (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Department of Medicine   (Japan)

^d KAGAWA UNIVERSITY   (Japan)

^e UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GREEN FLUORESCENT PROTEIN; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR PROLINE DIOXYGENASE; HYPOXIA INDUCIBLE FACTOR PROLINE DIOXYGENASE 1; HYPOXIA INDUCIBLE FACTOR PROLINE DIOXYGENASE 2; HYPOXIA INDUCIBLE FACTOR PROLINE DIOXYGENASE 3; PIMONIDAZOLE; UNCLASSIFIED DRUG;

ANEMIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; GENE INACTIVATION; GENE LOCUS; GENE REPRESSION; HORMONE SYNTHESIS; HYPOXIA; KIDNEY INJURY; KIDNEY PARENCHYMA; MOUSE; MYOFIBROBLAST; NONHUMAN; POLYCYTHEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; ANIMAL; BIOSYNTHESIS; CELL HYPOXIA; CYTOLOGY; KIDNEY; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL HYPOXIA; ERYTHROPOIETIN; KIDNEY; MICE; MYOFIBROBLASTS; SIGNAL TRANSDUCTION;

EID: 84970923265     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014121184     Document Type: Article

References (56)

1. Quaggin SE, Kapus A: Scar wars: mapping the fate of epithelialmesenchymal-myofibroblast transition. Kidney Int 80: 41-50, 2011
2. Nangaku M: Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 17: 17-25, 2006
3. Haase VH: Hypoxia-inducible factor signaling in the development of kidney fibrosis. Fibrogenesis Tissue Repair 5[Suppl 1 Proceedings of Fibroproliferative disorders: from biochemical analysis to targeted therapiesPetro E Petrides and David Brenner]: S16, 2012
4. Nangaku M, Rosenberger C, Heyman SN, Eckardt KU: Regulation of hypoxia-inducible factor in kidney disease. Clin Exp Pharmacol Physiol 40: 148-157, 2013
5. KouryMJ: Abnormal erythropoiesis and the pathophysiology of chronic anemia. Blood Rev 28: 49-66, 2014
6. Silverberg DS, Wexler D, Blum M, Schwartz D, Wollman Y, Iaina A: Erythropoietin should be part of congestive heart failure management. Kidney Int Suppl 87: S40-S47, 2003
7. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R: CarDiorenal syndrome. J AmColl Cardiol 52: 1527-1539, 2008
8. Risdon RA, Sloper JC, De Wardener HE: Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 2: 363-366, 1968
9. D'Amico G: Tubulointerstitium as predictor of progression of glomerular diseases. Nephron 83: 289-295, 1999
10. KrizW, Kaissling B, LeHirM: Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 121: 468-474, 2011
11. Boor P, Floege J: The renal (myo-)fibroblast: a heterogeneous group of cells. Nephrol Dial Transplant 27: 3027-3036, 2012
12. Maxwell PH, Osmond MK, Pugh CW, Heryet A, Nicholls LG, Tan CC, Doe BG, Ferguson DJP, Johnson MH, Ratcliffe PJ: Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 44: 1149-1162, 1993
13. Obara N, Suzuki N, Kim K, Nagasawa T, Imagawa S, Yamamoto M: Repression via the GATA box is essential for tissue-specific erythropoietin gene expression. Blood 111: 5223-5232, 2008
14. Yamazaki S, Souma T, Hirano I, Pan X,Minegishi N, Suzuki N, Yamamoto M: A mouse model of adult-onset anaemia due to erythropoietin deficiency. Nat Commun 4: 1950, 2013
15. Pan X, Suzuki N, Hirano I, Yamazaki S, Minegishi N, Yamamoto M: Isolation and characterization of renal erythropoietin-producing cells from genetically produced anemia mice. PLoS ONE 6: e25839, 2011
16. Suzuki N,Obara N, YamamotoM: Use of gene-manipulatedmice in the study of erythropoietin gene expression. Methods Enzymol 435: 157-177, 2007
17. Souma T, Yamazaki S,Moriguchi T, SuzukiN,Hirano I, Pan X, MinegishiN, AbeM, KiyomotoH, Ito S, Yamamoto M: Plasticity of renal erythropoietinproducing cells governs fibrosis. J AmSoc Nephrol 24: 1599-1616, 2013
18. Asada N, Takase M, Nakamura J, Oguchi A, Asada M, Suzuki N, Yamamura K, Nagoshi N, Shibata S, Rao TN, Fehling HJ, Fukatsu A, Minegishi N, Kita T, Kimura T, Okano H, Yamamoto M, Yanagita M: Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J Clin Invest 121: 3981-3990, 2011
19. LeBleu VS, Taduri G, O'Connell J, Teng Y, Cooke VG, Woda C, Sugimoto H, Kalluri R: Origin and function of myofibroblasts in kidney fibrosis. Nat Med 19: 1047-1053, 2013
20. Humphreys BD, Lin SL, Kobayashi A, Hudson TE,Nowlin BT, Bonventre JV, Valerius MT, McMahon AP, Duffield JS: Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176: 85-97, 2010
21. Maxwell PH, Ferguson DJ, Nicholls LG, Johnson MH, Ratcliffe PJ: The interstitial response to renal injury: fibroblast-like cells showphenotypic changes and have reduced potential for erythropoietin gene expression. Kidney Int 52: 715-724, 1997
22. Haase VH: Hypoxic regulation of erythropoiesis and iron metabolism. Am J Physiol Renal Physiol 299: F1-F13, 2010
23. Kim WY, SafranM, BuckleyMR, Ebert BL,Glickman J, BosenbergM, Regan M, KaelinWGJr: Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo. EMBO J 25: 4650-4662, 2006
24. Ratcliffe PJ: Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer. J Physiol 591: 2027-2042, 2013
25. Semenza GL:Oxygen homeostasis. Wiley Interdiscip Rev Syst BiolMed 2: 336-361, 2010
26. SemenzaGL:Oxygen sensing, homeostasis, and disease. NEngl JMed 365: 537-547, 2011
27. Semenza GL: Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 19: 176-182, 2004
28. Suzuki N, Obara N, Pan X, Watanabe M, Jishage K, Minegishi N, Yamamoto M: Specific contribution of the erythropoietin gene 39 enhancer to hepatic erythropoiesis after late embryonic stages. Mol Cell Biol 31: 3896-3905, 2011
29. Takeda K, Aguila HL, Parikh NS, Li X, Lamothe K, Duan LJ, Takeda H, Lee FS, Fong GH: Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Blood 111: 3229-3235, 2008
30. Gruber M, Hu CJ, Johnson RS, Brown EJ, Keith B, Simon MC: Acute postnatal ablation of Hif-2alpha results in anemia. Proc Natl Acad Sci U S A 104: 2301-2306, 2007
31. Minamishima YA,Moslehi J, BardeesyN, CullenD, Bronson RT, Kaelin WG Jr: Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood 111: 3236-3244, 2008
32. Koury ST, Koury MJ, BondurantMC, Caro J, Graber SE:Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration. Blood 74: 645-651, 1989
33. Koury MJ: Erythropoietin: the story of hypoxia and a finely regulated hematopoietic hormone. Exp Hematol 33: 1263-1270, 2005
34. Shoji K, Tanaka T, Nangaku M: Role of hypoxia in progressive chronic kidney disease and implications for therapy. Curr Opin Nephrol Hypertens 23: 161-168, 2014
35. Fraisl P, Aragonés J, Carmeliet P: Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat Rev Drug Discov 8: 139-152, 2009
36. Bernhardt WM,WiesenerMS, Scigalla P, Chou J, Schmieder RE, Günzler V, Eckardt KU: Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J Am Soc Nephrol 21: 2151-2156, 2010
37. Kramann R, Humphreys BD: Kidney pericytes: balancing regeneration and fibrosis. Semin Nephrol 34(4): 374-383, 2014
38. Sano H, Ichioka S, Sekiya N: Influence of oxygen on wound healing dynamics: assessment in a novel wound mouse model under a variable oxygen environment. PLoS ONE 7: e50212, 2012
39. Mimura I, Nangaku M: The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease. Nat Rev Nephrol 6: 667-678, 2010
40. Lendahl U, Lee KL, Yang H, Poellinger L: Generating specificity and diversity in the transcriptional response to hypoxia. Nat Rev Genet 10: 821-832, 2009
41. Wenger RH, StiehlDP, CamenischG: Integration of oxygen signaling at the consensus HRE. Sci STKE 2005: re12, 2005
42. Rankin EB, Biju MP, Liu Q, Unger TL, Rha J, Johnson RS, Simon MC, Keith B,Haase VH: Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 117: 1068-1077, 2007
43. Minamishima YA, Kaelin WG Jr: Reactivation of hepatic EPO synthesis in mice after PHD loss. Science 329: 407, 2010
44. Weidemann A, Kerdiles YM, Knaup KX, Rafie CA, Boutin AT, Stockmann C, Takeda N, Scadeng M, Shih AY, Haase VH, Simon MC, Kleinfeld D, Johnson RS: The glial cell response is an essential component of hypoxia-induced erythropoiesis in mice. J Clin Invest 119: 3373-3383, 2009
45. Rosenberger C,Mandriota S, Jürgensen JS,WiesenerMS,Hörstrup JH, Frei U, Ratcliffe PJ,Maxwell PH, Bachmann S, Eckardt KU: Expression of hypoxia-inducible factor-1alpha and-2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 13: 1721-1732, 2002
46. Takeda K, Ho VC, Takeda H, Duan LJ, Nagy A, Fong GH: Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2. Mol Cell Biol 26: 8336-8346, 2006
47. Ding M, Cui S, Li C, Jothy S, Haase V, Steer BM, Marsden PA, Pippin J, Shankland S, Rastaldi MP, Cohen CD, Kretzler M, Quaggin SE: Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice. NatMed 12: 1081-1087, 2006
48. Higgins DF, Kimura K, BernhardtWM, Shrimanker N, Akai Y, Hohenstein B, Saito Y, Johnson RS, Kretzler M, Cohen CD, Eckardt KU, Iwano M, Haase VH: Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 117: 3810-3820, 2007
49. Kobayashi H, Gilbert V, LiuQ, Kapitsinou PP, Unger TL, Rha J, Rivella S, Schlöndorff D, Haase VH: Myeloid cell-derived hypoxia-inducible factor attenuates inflammation in unilateral ureteral obstruction-induced kidney injury. J Immunol 188: 5106-5115, 2012
50. Kapitsinou PP, Sano H, Michael M, Kobayashi H, Davidoff O, Bian A, Yao B, Zhang MZ, Harris RC, Duffy KJ, Erickson-Miller CL, Sutton TA, Haase VH: Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury. J Clin Invest 124: 2396-2409, 2014
51. Moslehi J, Minamishima YA, Shi J, Neuberg D, Charytan DM, Padera RF, Signoretti S, Liao R, Kaelin WG Jr: Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy. Circulation 122: 1004-1016, 2010
52. Taniguchi CM, Finger EC, Krieg AJ, Wu C, Diep AN, LaGory EL,Wei K, McGinnis LM, Yuan J, Kuo CJ, Giaccia AJ: Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes. Nat Med 19: 1325-1330, 2013
53. Aragonés J, SchneiderM, Van Geyte K, Fraisl P,Dresselaers T, Mazzone M, Dirkx R, Zacchigna S, Lemieux H, Jeoung NH, Lambrechts D, Bishop T, Lafuste P,Diez-Juan A,Harten SK, Van Noten P,De Bock K,WillamC, Tjwa M, Grosfeld A, Navet R,Moons L, Vandendriessche T, Deroose C, Wijeyekoon B, Nuyts J, Jordan B, Silasi-Mansat R, Lupu F, Dewerchin M, Pugh C, Salmon P,Mortelmans L, Gallez B, Gorus F, Buyse J, Sluse F, Harris RA,Gnaiger E,Hespel P, VanHecke P, Schuit F, Van Veldhoven P, Ratcliffe P, Baes M, Maxwell P, Carmeliet P: Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 40: 170-180, 2008
54. Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, Ng LL, Palmiter RD, HawrylyczMJ, Jones AR, Lein ES, Zeng H: A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci 13: 133-140, 2010
55. Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, Shelton KD, Lindner J, Cherrington AD, Magnuson MA: Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem 274: 305-315, 1999
56. Nakano D, Kobori H, Burford JL, Gevorgyan H, Seidel S, Hitomi H, Nishiyama A, Peti-Peterdi J: Multiphoton imaging of the glomerular permeability of angiotensinogen. J Am Soc Nephrol 23: 1847-1856, 2012